Allan SE - Search Results

1

Defective regulatory and effector T cell functions in patients with FOXP3 mutations.

Bacchetta R, Passerini L, Gambineri E, Dai M, Allan SE, Perroni L, Dagna-Bricarelli F, Sartirana C, Matthes-Martin S, Lawitschka A, Azzari C, Ziegler SF, Levings MK, Roncarolo MG. Bacchetta R, et al. Among authors: allan se. J Clin Invest. 2006 Jun;116(6):1713-22. doi: 10.1172/JCI25112. J Clin Invest. 2006. PMID: 16741580 Free PMC article.

2

The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs.

Allan SE, Passerini L, Bacchetta R, Crellin N, Dai M, Orban PC, Ziegler SF, Roncarolo MG, Levings MK. Allan SE, et al. J Clin Invest. 2005 Nov;115(11):3276-84. doi: 10.1172/JCI24685. Epub 2005 Oct 6. J Clin Invest. 2005. PMID: 16211090 Free PMC article.

3

STAT5-signaling cytokines regulate the expression of FOXP3 in CD4+CD25+ regulatory T cells and CD4+CD25- effector T cells.

Passerini L, Allan SE, Battaglia M, Di Nunzio S, Alstad AN, Levings MK, Roncarolo MG, Bacchetta R. Passerini L, et al. Among authors: allan se. Int Immunol. 2008 Mar;20(3):421-31. doi: 10.1093/intimm/dxn002. Epub 2008 Feb 12. Int Immunol. 2008. PMID: 18270368

4

Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production.

Allan SE, Crome SQ, Crellin NK, Passerini L, Steiner TS, Bacchetta R, Roncarolo MG, Levings MK. Allan SE, et al. Int Immunol. 2007 Apr;19(4):345-54. doi: 10.1093/intimm/dxm014. Epub 2007 Feb 27. Int Immunol. 2007. PMID: 17329235

5

Generation of potent and stable human CD4+ T regulatory cells by activation-independent expression of FOXP3.

Allan SE, Alstad AN, Merindol N, Crellin NK, Amendola M, Bacchetta R, Naldini L, Roncarolo MG, Soudeyns H, Levings MK. Allan SE, et al. Mol Ther. 2008 Jan;16(1):194-202. doi: 10.1038/sj.mt.6300341. Epub 2007 Nov 6. Mol Ther. 2008. PMID: 17984976 Free article.

6

CD4+ T-regulatory cells: toward therapy for human diseases.

Allan SE, Broady R, Gregori S, Himmel ME, Locke N, Roncarolo MG, Bacchetta R, Levings MK. Allan SE, et al. Immunol Rev. 2008 Jun;223:391-421. doi: 10.1111/j.1600-065X.2008.00634.x. Immunol Rev. 2008. PMID: 18613849 Review.

7

Point mutants of forkhead box P3 that cause immune dysregulation, polyendocrinopathy, enteropathy, X-linked have diverse abilities to reprogram T cells into regulatory T cells.

McMurchy AN, Gillies J, Allan SE, Passerini L, Gambineri E, Roncarolo MG, Bacchetta R, Levings MK. McMurchy AN, et al. Among authors: allan se. J Allergy Clin Immunol. 2010 Dec;126(6):1242-51. doi: 10.1016/j.jaci.2010.09.001. Epub 2010 Oct 30. J Allergy Clin Immunol. 2010. PMID: 21036387

8

Functional dynamics of naturally occurring regulatory T cells in health and autoimmunity.

Levings MK, Allan S, d'Hennezel E, Piccirillo CA. Levings MK, et al. Adv Immunol. 2006;92:119-55. doi: 10.1016/S0065-2776(06)92003-3. Adv Immunol. 2006. PMID: 17145303 Review.

9

Human CD4+ T cells express TLR5 and its ligand flagellin enhances the suppressive capacity and expression of FOXP3 in CD4+CD25+ T regulatory cells.

Crellin NK, Garcia RV, Hadisfar O, Allan SE, Steiner TS, Levings MK. Crellin NK, et al. Among authors: allan se. J Immunol. 2005 Dec 15;175(12):8051-9. doi: 10.4049/jimmunol.175.12.8051. J Immunol. 2005. PMID: 16339542

10

Inducible reprogramming of human T cells into Treg cells by a conditionally active form of FOXP3.

Allan SE, Song-Zhao GX, Abraham T, McMurchy AN, Levings MK. Allan SE, et al. Eur J Immunol. 2008 Dec;38(12):3282-9. doi: 10.1002/eji.200838373. Eur J Immunol. 2008. PMID: 19039775 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

33 results

Search Page